Compare IMUX & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMUX | PESI |
|---|---|---|
| Founded | 2016 | 1990 |
| Country | United States | United States |
| Employees | 66 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Environmental Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.2M | 208.1M |
| IPO Year | 2013 | 1996 |
| Metric | IMUX | PESI |
|---|---|---|
| Price | $16.27 | $17.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | 140.8K | ★ 628.4K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.00 | ★ 43.61 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $642,000.00 |
| Revenue This Year | N/A | $34.62 |
| Revenue Next Year | N/A | $77.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.51 | $8.14 |
| 52 Week High | $16.86 | $21.32 |
| Indicator | IMUX | PESI |
|---|---|---|
| Relative Strength Index (RSI) | 66.47 | 54.42 |
| Support Level | $0.74 | $14.18 |
| Resistance Level | N/A | $18.40 |
| Average True Range (ATR) | 1.04 | 1.43 |
| MACD | 0.28 | -0.10 |
| Stochastic Oscillator | 90.27 | 38.76 |
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
Perma-Fix Environmental Services Inc is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include treatment and management of radioactive and mixed waste (waste containing both hazardous and low-level radioactive waste). The company operates through two segments: i) The treatment segment: It offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and ii) the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.